Trials / Completed
CompletedNCT01199536
Helicobacter Pylori Eradication Treatment in Patients With Duodenal Ulcers
Observational Study to Evaluate Helicobacter Pylori Eradication at the End of Routine Triple Eradication Therapy With Duodenal Ulcer Relapses Control.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 59 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The Study purpose is to evaluate Helicobacter pylori susceptibility to Clarithromycin and to estimate eradication and healing rates of duodenal ulcer routine eradication therapy at the end of treatment and 52 weeks from the therapy start
Conditions
Timeline
- Start date
- 2010-11-01
- Primary completion
- 2013-11-01
- Completion
- 2013-11-01
- First posted
- 2010-09-13
- Last updated
- 2013-11-25
Locations
1 site across 1 country: Russia
Source: ClinicalTrials.gov record NCT01199536. Inclusion in this directory is not an endorsement.